Aurora Spine Corporation
ASAPF
$0.19
-$0.02-9.52%
| Weiss Ratings | ASAPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ASAPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ASAPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.95 | |||
| Price History | ASAPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -22.26% | |||
| 30-Day Total Return | -17.14% | |||
| 60-Day Total Return | -42.32% | |||
| 90-Day Total Return | -36.20% | |||
| Year to Date Total Return | -31.26% | |||
| 1-Year Total Return | -13.64% | |||
| 2-Year Total Return | -21.49% | |||
| 3-Year Total Return | -41.90% | |||
| 5-Year Total Return | 99.79% | |||
| 52-Week High % Change | -44.23% | |||
| 52-Week Low % Change | 17.57% | |||
| Price | ASAPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.34 | |||
| 52-Week Low Price | $0.16 | |||
| 52-Week Low Price (Date) | May 28, 2024 | |||
| 52-Week High Price (Date) | Oct 25, 2024 | |||
| Valuation | ASAPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 15.29M | |||
| Enterprise Value | 17.98M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -74.62% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.87 | |||
| Price/Book (Q) | 2.93 | |||
| Enterprise Value/Revenue (TTM) | 1.06 | |||
| Price | $0.19 | |||
| Enterprise Value/EBITDA (TTM) | 73.62 | |||
| Enterprise Value/EBIT | -39.30 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ASAPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 77.42M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ASAPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 760 424 2004 | |||
| Address | 20 Holly Street Toronto, ON M4S 3B1 | |||
| Website | www.aurora-spine.com | |||
| Country | Canada | |||
| Year Founded | 2013 | |||
| Profitability | ASAPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -2.70% | |||
| Profit Margin | -3.75% | |||
| Management Effectiveness | ASAPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -2.50% | |||
| Return on Equity | -- | |||
| Income Statement | ASAPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 16.90M | |||
| Total Revenue (TTM) | 16.90M | |||
| Revenue Per Share | $0.22 | |||
| Gross Profit (TTM) | 10.21M | |||
| EBITDA (TTM) | 244.20K | |||
| EBIT (TTM) | -457.50K | |||
| Net Income (TTM) | -635.50K | |||
| Net Income Avl. to Common (TTM) | -635.50K | |||
| Total Revenue Growth (Q YOY) | 20.70% | |||
| Earnings Growth (Q YOY) | 128.49% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 125.00% | |||
| Balance Sheet | ASAPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 882.10K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 8.76M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 5.02M | |||
| Current Ratio (Q) | 2.399 | |||
| Book Value Per Share (Q) | $0.06 | |||
| Total Assets (Q) | 12.09M | |||
| Total Current Liabilities (Q) | 3.65M | |||
| Total Debt (Q) | 3.70M | |||
| Total Liabilities (Q) | 7.07M | |||
| Total Common Equity (Q) | 5.02M | |||
| Cash Flow | ASAPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -388.60K | |||
| Cash from Financing (TTM) | 1.03M | |||
| Net Change in Cash (TTM) | 508.60K | |||
| Levered Free Cash Flow (TTM) | -449.20K | |||
| Cash from Operations (TTM) | -136.00K | |||
